Impax Receives FDA Approval For Generic Precose(R) Tablets, 25 Mg, 50 Mg And 100 Mg (Medical News Today)
Impax Laboratories, Inc. (NASDAQ: IPXL) confirmed that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Abbreviated New Drug Application (ANDA) for generic versions of Precose Tablets (acarbose), 25 mg, 50 mg and 100 mg strengths. Precose , a Bayer HealthCare Pharmaceuticals product, is used in the management of type two diabetes mellitus.

FDA Approves Samsca To Treat Hyponatremia (Medical News Today)
The U.S. Food and Drug Administration has approved Samsca tablets (tolvaptan) to treat hyponatremia, an abnormally low concentration of sodium in the blood. "With the approval of Samsca, physicians will have an additional tool to treat hyponatremia," said Norman Stockbridge, M.D., director of the Division of Cardiovascular and Renal Products in the FDA's Center for Drug Evaluation and Research.